Uma N. M. Rao, MD
Professor of Pathology
Dr. Uma Rao is a member of the Division of Anatomic Pathology and Director of the Bone, Soft Tissue, and Melanoma Center of Excellence.
Rm. 2.9 West Wing
Pittsburgh, PA 15232
Office Telephone: 412-623-2319
- MBBS - Government Medical College, Mysore University, Mysore, India, 1968
Research InterestsDr. Rao is interested in cytogenetics, immunohistochemical and molecular analysis of bone and soft tissue tumors and melanoma. She is the reference pathologist for the melanoma center at UPCI, and major participant in the Melanoma section of the Eastern Cooperative Oncology Group.
- Bone, soft tissue, and melanoma pathology
- Oncologic pathology
Selected PublicationsView Dr. Rao's publications on PubMed
Rao UN, Hood BL, Jones-Laughner JM, Sun M, Conrads TP. Distinct profiles of oxidative stress-related and matrix proteins in adult bone and soft tissue osteosarcoma and desmoid tumors: A proteomics study. Hum Pathol. 2012 Oct 11. pii: S0046-8177(12)00274-2. doi: 10.1016/j.humpath.2012.06.023. [Epub ahead of print]
Immunohistochemical analysis of the endo ribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Papachristou DJ, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao UN. Histopathology. 2012 Mar 6. doi: 10.1111/j.1365-2559.2012.04192.x. [Epub 2011 Dec 13.
Papachristou DJ, Rao UN, Korpetinou A, Giannopoulou E, Sklirou E, Kontogeorgakos V, Kalofonos HP.Prognostic significance of Dicer cellular levels in soft tissue sarcomas. Cancer Invest. 2011 Feb;30(2):172-9.
Cajaiba MM, Jianhua Luo, Goodman MA, Fuhrer KA, Rao UN. Sox9 expression is not limited to chondroid neoplasms: variable occurrence in other soft tissue and bone tumors with frequent expression by synovial sarcomas. Int J Surg Pathol. 2010 Oct;18(5):319-23. Epub 2010 May 18.
Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, Kirkwood JM, Panelli MC. Microrna profiling analysis of differences between the melanoma of young adults and older adults. J Transl Med. 2010 Mar 19;8(1):27.
Rao UN, Lee SJ, Luo W, Mihm MC Jr, Kirkwood JM. Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials. Am J Clin Pathol. 2010 Apr;133(4):646-53.
Papachristou DJ, Palekar A, Surti U, Cieply K, McGough RL, Rao UN. Malignant granular cell tumor of the ulnar nerve with novel cytogenetic and molecular genetic findings. Cancer Genet Cytogenet. 2009 May;191(1):46-50.
Wang W, Edington HD, Rao UN, Jukic DM, Radfar A, Wang H, Kirkwood JM. Effects of high-dose IFNalpha2b on regional lymph node metastases of human melanoma: modulation of STAT5, FOXP3, and IL-17. Clin Cancer Res. 2008 Dec 15;14(24):8314-20.
Raab SS, Grzybicki DM, Mahood LK, Parwani AV, Kuan SF, Rao UN. Effectiveness of random and focused review in detecting surgical pathology error. Am J Clin Pathol. 2008 Dec;130(6):905-12.
Papachristou DJ, Gkretsi V, Rao UN, Papachristou GI, Papaefthymiou OA, Basdra EK, Wu C, Papavassiliou AG. Expression of integrin-linked kinase and its binding partners in chondrosarcoma: association with prognostic significance. Eur J Cancer. 2008 Nov;44(16):2518-25. Epub 2008 Aug 20.
Wang W, Edington HD, Rao UN, Jukic DM, Wang H, Shipe-Spotloe JM, Kirkwood JM. STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy. J Invest Dermatol. 2008 Aug;128(8):1997-2002. Epub 2008 Feb 28.
Armah HA, McGough RL, Goodman MA, Gollin SM, Surti U, Parwani AV, Rao UN. Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites. Diagn Patholo, 2007; 2(1):44.
Wang W, Edington HD, Rao UN, Jukic DM, Wang H, Shipe-Spotloe JM, Kirkwood JM. STAT 3 as a Biomarker of Progression in Atypical Nevi of Patients with Melanoma: Dose-Response Effects of Systemic IFNalpha Therapy. J Invest Dermatol. 2008